๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The primary objective of this study is to determine if the combination regi...
Status
Terminated
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01377376
Treatments Being Tested
The primary objective of this study is to examine if the combination regime...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01580735
Treatments Being Tested
This is a phase I study to determine the safety, tolerability and recommend...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01251796
Treatments Being Tested
This study is to determine if the combination regimen of tivantinib with er...
Status
Terminated
Location
Multiple Locations
Start Date
2011-01-11
Trial ID
NCT01244191
Treatments Being Tested
The purpose of this study is to evaluate progression-free survival among su...
Status
Completed
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01395758
Treatments Being Tested
This is a phase I study to determine the safety, tolerability and recommend...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01069757
Treatments Being Tested
This is a randomized, placebo-controlled, double blind phase 2 study design...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00777309
This is an extension study that will allow participants to continue to rece...
Status
Completed
Location
Multiple Locations
Start Date
2010-08-31
Trial ID
NCT01178411
Treatments Being Tested
To determine the safety, tolerability and recommended Phase 2 dose of ARQ 1...
Status
Completed
Location
San Diego Pacific Oncology and Hematology Associates Inc.
Start Date
2008-02
Trial ID
NCT00612703
Treatments Being Tested
This randomized phase II trial studies how well tivantinib with or without ...
Status
Completed
Location
University of Arizona Cancer Center-Orange Grove Campus
Start Date
2012-08-20
Trial ID
NCT01688973
Treatments Being Tested